Charnley Femoral Component
by Codman & Shurtleff, Inc. 510(k)
Active
510(k) K760974
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK760974 | Date16 Nov 1976 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- JDG
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3360
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Charnley Femoral Component is a cemented, metal hip prosthesis designed for use in total hip arthroplasty. It is intended to replace the femoral head and neck, providing stability and restoring function to the hip joint by articulating with a femoral acetabular component.
This device is supplied as a reusable surgical implant and is classified under FDA product code JDG as a Class II medical device under special controls. It was granted FDA 510(k) clearance (K760974) in 1976 under regulation 888.3360, with a decision of Substantially Equivalent (SESE). Multiple registration numbers and FEI numbers are associated with its variants, reflecting its regulatory filing history.
Other devices from Codman & Shurtleff, Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the Charnley Femoral Component used for in total hip arthroplasty procedures?
The Charnley Femoral Component is designed to replace the femoral head and neck during total hip arthroplasty, providing stability and restoring function to the hip joint. It is cemented in place and articulates with a femoral acetabular component to mimic the natural movement of the hip.
Is the Charnley Femoral Component intended for single-use or can it be reused in multiple surgeries?
The Charnley Femoral Component is explicitly described as a reusable surgical implant. It is not intended for single-use, but rather for repeated use in multiple procedures, adhering to proper sterilization and handling protocols.
What regulatory pathway was followed for FDA clearance of this device, and when was it approved?
The Charnley Femoral Component received FDA 510(k) clearance under the traditional review pathway in 1976 (K760974). It was classified as Substantially Equivalent (SESE) to a predicate device and falls under FDA product code JDG, categorized as a Class II orthopedic implant.
Does the Charnley Femoral Component come in multiple sizes or models, and how are they differentiated?
While the provided data does not specify exact sizes or model variations in detail, the device has multiple FEI (Firm Establishment Identification) numbers and registration numbers listed, indicating it exists in several variants. These likely correspond to different femoral sizes or designs to accommodate varying patient anatomies. For precise sizing, refer to the manufacturer’s catalog or surgical guides.